Profile
Serguei Nabirotchkine is the founder.
He founded Pharnext SA in 2007 and currently holds the title of Vice President & Head-Systems Biology.
Dr. Nabirotchkine also held the position of Director-Animal Model Department at Serono Genetics Institute SA.
Serguei Nabirotchkine active positions
| Companies | Position | Start |
|---|---|---|
| PHARNEXT SCA | Founder | 2006-12-31 |
Former positions of Serguei Nabirotchkine
| Companies | Position | End |
|---|---|---|
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Private companies | 1 |
|---|---|
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
- Stock Market
- Insiders
- Serguei Nabirotchkine
